ConductScience.org, home
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
API referenceFor AI assistants

Trial · NCT03595917

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 13 of 13

Download this page as JSON
ListOutcomeTime frameDescription
PrimaryMaximum tolerated dose (MTD) of ABL00142 Days
To define the maximum tolerated dose (MTD) of ABL001 for participants with BCR-ABL positive (BCR-ABL+) B-cell acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia (CML) in lymphoid blast crisis.
SecondaryPercentage for Participants Achieving Hematologic Remission28 Days
SecondaryPercentage for Participants Achieving Hematologic Remission56 Days
SecondaryPercentage for Participants Achieving Hematologic Remission85 Days
SecondaryPercentage of participants achieving cytogenetic response28 Days
SecondaryPercentage of participants achieving cytogenetic response56 Days
SecondaryPercentage of participants achieving cytogenetic response85 Days
SecondaryPercentage of participants achieving a minimal residual disease (MRD)-negative CR by flow cytometry85 Days
SecondaryPercentage of participants achieving a minimal residual disease (MRD)-negative CR by flow cytometry28 Days
SecondaryPercentage of participants achieving a minimal residual disease (MRD)-negative CR by flow cytometry56 Days
SecondaryPercentage of participants achieving molecular response28 Days
SecondaryPercentage of participants achieving molecular response56 Days
SecondaryPercentage of participants achieving molecular response85 Days

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03595917/registered

API referenceFor AI assistants